People with Type 2 diabetes from the south coast of England are invited to participate in an exercise project. Participants need to be registered with a
Fractyl Health has activated the 10th clinical site in its REVITA-T2Di trial in the United States and Europe. The trial is a prospective, randomised, double-blind,
Biomarkers in the eyes could play a part in helping manage diabetic retinopathy and potentially diabetes, says new research from the Indiana University School of
Results of an AI technology trial at Barts Health NHS Trust show potential to prevent thousands of people with diabetes from limb amputation. The study
ViaCyte has closed a $45m Series D financing tranche in the United States, bringing the total round to more than $115m, reports DrugDeliveryBusiness.com. The funding will
Molecules found in tarantula venom could offer a new treatment option for people living with Type 2 diabetes. The early-stage research, presented at the Diabetes
A pharmaceutical company has announced positive results from its phase Ib clinical study on its drug for neuropathic pain. AlzeCure develops a broad portfolio of
Approximately 9 in 10 specialists agree that people with Type 2 diabetes whose healthcare professionals (HCPs) collaborate tend to have better outcomes than those whose
According to researchers, blood glucose levels in young people with Type 1 diabetes improved during Britain’s first national lockdown in 2020. The team compared how
A landmark trial shows that an immunotherapy drug can delay Type 1 diabetes by an average of three years. Previously, in 2019, researchers from the
